• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10620
Device Problems Defective Device (2588); Difficult to Advance (2920)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/24/2019
Event Type  malfunction  
Manufacturer Narrative
Device is a combination product.A 3.50 x 24mm synergy stent delivery system was returned for analysis.Examination of the crimped stent identified distal stent damage.Stent struts at the proximal end of the stent were flared outwards and damaged.Damage was noted to the most distal stent strut row with struts lifted and pulled back distally.The undamaged crimped stent outer diameter was measured using snap gauge and was within max crimped stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.There was no evidence of a balloon profile issue.A visual and tactile examination of the hypotube found no issues.A visual and tactile examination of shaft polymer extrusion revealed no issues.Examination of the tip found damage to the tip.Device was loaded onto and tracked over a 0.014 inch guidewire without issue.An attempt was made to insert the device into a 5fr guide catheter however the device could not be inserted.The distal end of the stent met resistance which appeared to be due to the stent damage.An attempt was made to insert the device into a 6fr guide catheter, the device was inserted into and advanced through and withdrawn from the 6 fr guide catheter without issue.No other issues were identified during the product analysis.
 
Event Description
Reportable based on analysis completed on 30oct2019.It was reported that the balloon was already inflated prior to use.A percutaneous coronary intervention was being performed.During prep, the 3.50 x 24mm synergy ii drug-eluding stent balloon was noted to be expanded at its proximal and distal ends and could not be introduced.The procedure was successfully completed without issue or patient injury.However, returned device analysis revealed stent damage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key9345097
MDR Text Key171994507
Report Number2134265-2019-13689
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodePE
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial
Report Date 11/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/19/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/11/2019
Device Model Number10620
Device Catalogue Number10620
Device Lot Number0021921349
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/01/2019
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/30/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/15/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-